191 related articles for article (PubMed ID: 34751398)
1. Crohn's Disease and Early Exposure to Thiopurines are Independent Risk Factors for Mosaic Chromosomal Alterations in Patients with Inflammatory Bowel Diseases.
Kakuta Y; Iwaki H; Umeno J; Kawai Y; Kawahara M; Takagawa T; Shimoyama Y; Naito T; Moroi R; Kuroha M; Shiga H; Watanabe K; Nakamura S; Nakase H; Sasaki M; Hanai H; Fuyuno Y; Hirano A; Matsumoto T; Kudo H; Minegishi N; Nakamura M; Hisamatsu T; Andoh A; Nagasaki M; Tokunaga K; Kinouchi Y; Masamune A;
J Crohns Colitis; 2022 May; 16(4):643-655. PubMed ID: 34751398
[TBL] [Abstract][Full Text] [Related]
2. Correlations between genetically predicted lipid-lowering drug targets and inflammatory bowel disease.
Huang K; Huang S; Xiong M
Lipids Health Dis; 2024 Jan; 23(1):31. PubMed ID: 38287401
[TBL] [Abstract][Full Text] [Related]
3. Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study.
Alexakis C; Saxena S; Chhaya V; Cecil E; Curcin V; Pollok R
Inflamm Bowel Dis; 2017 Apr; 23(4):672-680. PubMed ID: 28151735
[TBL] [Abstract][Full Text] [Related]
4. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
[TBL] [Abstract][Full Text] [Related]
5. Thiopurines Have Sustained Long-term Effectiveness in Patients with Inflammatory Bowel Disease, Which is Independent of Disease Duration at Initiation: A Propensity Score Matched Analysis.
Ranjan MK; Kumar P; Vuyyuru SK; Kante B; Mundhra SK; Golla R; Virmani S; Sharma R; Sahni P; Das P; Kalaivani M; Upadhyay AD; Makharia G; Kedia S; Ahuja V
J Crohns Colitis; 2024 Feb; 18(2):192-203. PubMed ID: 37584328
[TBL] [Abstract][Full Text] [Related]
6. Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study.
Biancone L; Zuzzi S; Ranieri M; Petruzziello C; Calabrese E; Onali S; Ascolani M; Zorzi F; Condino G; Iacobelli S; Pallone F
J Crohns Colitis; 2012 Jun; 6(5):578-87. PubMed ID: 22398047
[TBL] [Abstract][Full Text] [Related]
7. Different Profile of Efficacy of Thiopurines in Ulcerative Colitis and Crohn's Disease.
Rispo A; Testa A; De Palma GD; Donetto S; Diaferia M; Musto D; Nardone O; Maione F; Caporaso N; Castiglione F
Inflamm Bowel Dis; 2015 Nov; 21(11):2570-5. PubMed ID: 26222340
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study.
Biancone L; Armuzzi A; Scribano ML; D'Inca R; Castiglione F; Papi C; Angelucci E; Daperno M; Mocciaro F; Riegler G; Fries W; Meucci G; Alvisi P; Spina L; Ardizzone S; Petruzziello C; Ruffa A; Kohn A; Vecchi M; Guidi L; Di Mitri R; Renna S; Emma C; Rogai F; Rossi A; Orlando A; Pallone F;
J Crohns Colitis; 2016 Aug; 10(8):913-24. PubMed ID: 26933032
[TBL] [Abstract][Full Text] [Related]
9. Causal Association Between Atopic Dermatitis and Inflammatory Bowel Disease: A 2-Sample Bidirectional Mendelian Randomization Study.
Meisinger C; Freuer D
Inflamm Bowel Dis; 2022 Oct; 28(10):1543-1548. PubMed ID: 34964870
[TBL] [Abstract][Full Text] [Related]
10. Thiopurines: Use them or lose them? International survey on current and future use of thiopurines in inflammatory bowel disease.
Sousa P; Ministro P; Armuzzi A; Dignass A; Høivik ML; Barreiro-de Acosta M; Vavricka S; Saad-Hossne R; Kotze PG; Peyrin-Biroulet L; Magro F
Dig Liver Dis; 2021 Dec; 53(12):1571-1579. PubMed ID: 34187768
[TBL] [Abstract][Full Text] [Related]
11. Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients.
Rosen MJ; Karns R; Vallance JE; Bezold R; Waddell A; Collins MH; Haberman Y; Minar P; Baldassano RN; Hyams JS; Baker SS; Kellermayer R; Noe JD; Griffiths AM; Rosh JR; Crandall WV; Heyman MB; Mack DR; Kappelman MD; Markowitz J; Moulton DE; Leleiko NS; Walters TD; Kugathasan S; Wilson KT; Hogan SP; Denson LA
Gastroenterology; 2017 May; 152(6):1345-1357.e7. PubMed ID: 28132889
[TBL] [Abstract][Full Text] [Related]
12. Causal Association Between Inflammatory Bowel Disease and Psoriasis: A Two-Sample Bidirectional Mendelian Randomization Study.
Li Y; Guo J; Cao Z; Wu J
Front Immunol; 2022; 13():916645. PubMed ID: 35757704
[TBL] [Abstract][Full Text] [Related]
13. Risk of haematopoietic cancer in patients with inflammatory bowel disease.
Askling J; Brandt L; Lapidus A; Karlén P; Björkholm M; Löfberg R; Ekbom A
Gut; 2005 May; 54(5):617-22. PubMed ID: 15831904
[TBL] [Abstract][Full Text] [Related]
14. Impact of early thiopurines on surgery in 2770 children and young people diagnosed with inflammatory bowel disease: a national population-based study.
Chhaya V; Pollok RC; Cecil E; Subramanian V; Curcin V; Majeed A; Saxena S
Aliment Pharmacol Ther; 2015 Oct; 42(8):990-9. PubMed ID: 26271196
[TBL] [Abstract][Full Text] [Related]
15. Cancer Risk in the Early Stages of Inflammatory Bowel Disease in Korean Patients: A Nationwide Population-based Study.
Jung YS; Han M; Park S; Kim WH; Cheon JH
J Crohns Colitis; 2017 Aug; 11(8):954-962. PubMed ID: 28333358
[TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP.
Zhernakova A; Festen EM; Franke L; Trynka G; van Diemen CC; Monsuur AJ; Bevova M; Nijmeijer RM; van 't Slot R; Heijmans R; Boezen HM; van Heel DA; van Bodegraven AA; Stokkers PC; Wijmenga C; Crusius JB; Weersma RK
Am J Hum Genet; 2008 May; 82(5):1202-10. PubMed ID: 18439550
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory bowel disease and risk of small bowel cancer: a binational population-based cohort study from Denmark and Sweden.
Axelrad JE; Olén O; Sachs MC; Erichsen R; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
Gut; 2021 Feb; 70(2):297-308. PubMed ID: 32474410
[TBL] [Abstract][Full Text] [Related]
18. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
19. The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea.
Lee HS; Park SH; Yang SK; Ye BD; Kim JH; Kim SO; Soh JS; Lee S; Bae JH; Lee HJ; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
Scand J Gastroenterol; 2015 Feb; 50(2):188-96. PubMed ID: 25515241
[TBL] [Abstract][Full Text] [Related]
20. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
